The 20 Best EGFR Positive Lung Cancer Doctors near Newton, MA

Lecia Van Dam Sequist is an Oncologist in Waltham, Massachusetts. Dr. Van Dam Sequist is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy.

Daniel Costa is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Costa is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.

Deepa Rangachari is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Rangachari is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Thymectomy.

Michael Rabin is an Oncologist in Boston, Massachusetts. Dr. Rabin is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.

Geoffrey Oxnard is an Oncologist in Boston, Massachusetts. Dr. Oxnard is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Tissue Biopsy.

Revati Rao is an Oncologist in Newton, Massachusetts. Dr. Rao is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Pleuropulmonary Blastoma.

Pasi Janne is an Oncologist in Boston, Massachusetts. Dr. Janne is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lung Cancer, Lung Adenocarcinoma, and Tissue Biopsy.

David Jackman is an Oncologist in Boston, Massachusetts. Dr. Jackman is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Mesothelioma.

Alice Shaw is an Oncologist in Boston, Massachusetts. Dr. Shaw is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Bruce Johnson is an Oncologist in Boston, Massachusetts. Dr. Johnson is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and EGFR Positive Lung Cancer.

Rebecca Suk Heist is an Oncologist in Boston, Massachusetts. Dr. Suk Heist is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).

Zofia Piotrowska is an Oncologist in Boston, Massachusetts. Dr. Piotrowska is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Justin Gainor is an Oncologist in Boston, Massachusetts. Dr. Gainor is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and EGFR Positive Lung Cancer.

Peter Lacamera is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Brighton, Massachusetts. Dr. Lacamera is rated as an Experienced provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Gastrostomy, and Endoscopy. Dr. Lacamera is currently accepting new patients.

Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy.  He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

David Kozono is a Radiation Oncologist in Boston, Massachusetts. Dr. Kozono is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Michael Kent is a Thoracic Surgeon and a General Surgeon in Boston, Massachusetts. Dr. Kent is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, Endoscopy, and Gastrostomy.

Sidharta Gangadharan is a Thoracic Surgeon in Boston, Massachusetts. Dr. Gangadharan is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Tracheobronchomalacia, Acquired Tracheomalacia, Lung Nodules, Endoscopy, and Gastrectomy.

Dr. Steven J. Mentzer is a thoracic surgeon at Brigham and Women’s Hospital and Dana-Farber Brigham Cancer Center. He is a professor of surgery at Harvard Medical School.Dr. Mentzer received his medical degree from the University of Minnesota and received his general surgical residency training at the Brigham. He completed a cardiothoracic surgery fellowship at the University of Toronto. Dr. Mentzer also completed a research fellowship at Dana-Farber Cancer Institute where he investigated the molecular mechanisms involved in the regulation of T lymphocyte function. He is board certified in surgery, cardiothoracic surgery, and surgical critical care.Dr. Mentzer’s clinical interests include diseases of the lungs and thoracic cancers, minimally invasive surgery of the lungs and esophagus, and minimally invasive surgery for esophageal cancer. Principal investigator for The Mentzer Lab, Dr. Mentzer is currently studying the adaptive processes involved in blood vessel growth (angiogenesis) and lung regeneration. Dr. Mentzer is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), ALK-Positive Non-Small Cell Lung Cancer, Gastrostomy, and Endoscopy.

Dr. Jon Wee is the Esophageal Surgery Section Chief, Director of Robotics in Thoracic Surgery, and co-Director of Minimally Invasive Thoracic Surgery at Brigham and Women’s Hospital. He is also an Associate Program Director for Thoracic Surgery and is an Assistant Professor of Surgery at Harvard Medical School.Dr. Wee received his medical degree from the Duke University School of Medicine and completed his surgical training at Brigham and Women’s Hospital. He then went on to complete his cardiothoracic surgery training at the University of Pittsburgh Medical Center. He is board certified in surgery and thoracic surgery.Dr. Wee’s clinical interest is in minimally invasive approaches to thoracic diseases. These include minimally invasive and robotic esophagectomy, lobectomy, thymectomy and mediastinal resection for thoracic malignancies.  In addition, he treats benign esophageal disease such as gastro-esophageal reflux disease, giant paraesophageal hernias, diverticulum, etc. He performs POEM procedures for achalasia as well as sympathectomy for hyperhidrosis and endoluminal therapies such as PDT, laser, and stents for palliation. His research interest is in the use of minimally invasive techniques to decrease pain, improve recovery, and improve ultimate outcomes. Dr. Wee is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Endoscopy, and Thymectomy.